PL1858488T3 - Kompozycje tygecykliny i sposoby wytwarzania - Google Patents

Kompozycje tygecykliny i sposoby wytwarzania

Info

Publication number
PL1858488T3
PL1858488T3 PL06737947T PL06737947T PL1858488T3 PL 1858488 T3 PL1858488 T3 PL 1858488T3 PL 06737947 T PL06737947 T PL 06737947T PL 06737947 T PL06737947 T PL 06737947T PL 1858488 T3 PL1858488 T3 PL 1858488T3
Authority
PL
Poland
Prior art keywords
preparation
methods
tigecycline compositions
tigecycline
compositions
Prior art date
Application number
PL06737947T
Other languages
English (en)
Other versions
PL1858488T5 (pl
Inventor
Mahdi B Fawzi
Tianmin Zhu
Syed M Shah
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36648809&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1858488(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PL1858488T3 publication Critical patent/PL1858488T3/pl
Publication of PL1858488T5 publication Critical patent/PL1858488T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL06737947.9T 2005-03-14 2006-03-13 Kompozycje tygecykliny i sposoby wytwarzania PL1858488T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66103005P 2005-03-14 2005-03-14
EP06737947.9A EP1858488B2 (en) 2005-03-14 2006-03-13 Tigecycline compositions and methods of preparation
PCT/US2006/008827 WO2006099258A1 (en) 2005-03-14 2006-03-13 Tigecycline compositions and methods of preparation

Publications (2)

Publication Number Publication Date
PL1858488T3 true PL1858488T3 (pl) 2014-01-31
PL1858488T5 PL1858488T5 (pl) 2024-01-03

Family

ID=36648809

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06737947.9T PL1858488T5 (pl) 2005-03-14 2006-03-13 Kompozycje tygecykliny i sposoby wytwarzania

Country Status (25)

Country Link
US (5) US7879828B2 (pl)
EP (1) EP1858488B2 (pl)
JP (1) JP4972081B2 (pl)
KR (2) KR20130122988A (pl)
CN (2) CN101132775A (pl)
AR (2) AR053827A1 (pl)
AU (1) AU2006223226B2 (pl)
BR (1) BRPI0608464A2 (pl)
CA (1) CA2602089C (pl)
CR (1) CR9416A (pl)
CY (1) CY1114504T1 (pl)
DK (1) DK1858488T4 (pl)
ES (1) ES2434944T5 (pl)
GT (1) GT200600112A (pl)
HN (1) HN2006011218A (pl)
IL (1) IL185924A (pl)
MX (1) MX2007010983A (pl)
NO (1) NO20074278L (pl)
PE (1) PE20061107A1 (pl)
PL (1) PL1858488T5 (pl)
PT (1) PT1858488E (pl)
RU (1) RU2428190C2 (pl)
TW (1) TW200700092A (pl)
WO (1) WO2006099258A1 (pl)
ZA (1) ZA200707831B (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1858488B2 (en) 2005-03-14 2022-07-20 Wyeth LLC Tigecycline compositions and methods of preparation
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
AR055336A1 (es) * 2005-06-16 2007-08-22 Wyeth Corp Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US20070244335A1 (en) * 2006-04-17 2007-10-18 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
ES2622356T3 (es) * 2006-04-24 2017-07-06 Teva Pharmaceutical Industries, Ltd. Formas cristalinas de tigeciclina y procesos para su preparación
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
PT2271348T (pt) * 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
US9107929B2 (en) 2008-05-01 2015-08-18 Ranbaxy Laboratories Limited Stable parenteral formulations of tigecycline
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
CN102138925B (zh) * 2010-01-29 2014-06-25 正大天晴药业集团股份有限公司 替加环素组合物及其制备方法
PT2568987T (pt) 2010-05-12 2017-02-03 Rempex Pharmaceuticals Inc Composições de tetraciclina
WO2012169435A1 (ja) 2011-06-07 2012-12-13 旭化成ファーマ株式会社 高純度ｐｔｈ含有凍結乾燥製剤およびその製造方法
CN102391148B (zh) * 2011-10-24 2014-01-08 江苏奥赛康药业股份有限公司 一种高纯度替加环素的合成方法
CN103315947B (zh) 2012-03-22 2016-01-20 上海汇伦生命科技有限公司 一种注射用替加环素组合物
CN103356662B (zh) * 2012-03-27 2015-11-25 浙江医药股份有限公司新昌制药厂 注射用替加环素组合物及其制备方法
CN102641249A (zh) * 2012-05-06 2012-08-22 江苏奥赛康药业股份有限公司 一种替加环素组合物的制备方法
CN103417498B (zh) * 2012-05-18 2017-09-12 山东新时代药业有限公司 一种替加环素冻干粉针剂的制备方法
CN102697739B (zh) * 2012-05-31 2014-10-29 丽珠医药集团股份有限公司 一种减少替加环素差向异构体化的粉针剂制备方法
CN102911077B (zh) * 2012-11-12 2015-01-07 成都百裕科技制药有限公司 4r-替加环素的制备方法
IN2013MU01127A (pl) * 2013-03-26 2015-05-01 Astron Res Ltd
WO2014167575A2 (en) * 2013-03-26 2014-10-16 Astron Research Limited Stable tigecycline composition
CN104107170A (zh) * 2013-04-22 2014-10-22 上海汇伦生命科技有限公司 一种替加环素组合物
US20140323443A1 (en) * 2013-04-30 2014-10-30 Fresenius Kabi Usa, Llc Tigecycline formulations
US20160143925A1 (en) 2013-11-12 2016-05-26 Galenicum Health S.L. Stable pharmaceutical compositions
NO2723977T3 (pl) 2014-03-19 2018-03-10
CN105079816B (zh) * 2015-08-17 2018-09-07 江苏豪森药业集团有限公司 替加环素药物组合物及其制备方法
CN108653216B (zh) * 2018-05-28 2020-12-18 福安药业集团湖北人民制药有限公司 注射用替加环素
WO2021063468A1 (en) 2019-10-02 2021-04-08 Anfarm Hellas S.A. Stable parenteral pharmaceutical composition containing tigecycline and process for the preparation thereof
CN113582870A (zh) * 2020-05-01 2021-11-02 复旦大学附属华山医院 一种恢复替加环素抗菌活性的方法
IT202100031133A1 (it) 2021-12-13 2023-06-13 Zambon Spa Composizione farmaceutica comprendente tigeciclina

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH225704A (de) 1942-01-06 1943-02-15 Schlotterbeck Automobile Aktie Holzgasgenerator.
GB901107A (en) 1959-06-29 1962-07-11 Pfizer Therapeutic composition and method of preparing same
US3026248A (en) 1959-09-11 1962-03-20 Pfizer & Co C Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents
US3106512A (en) 1961-07-19 1963-10-08 Olin Mathieson Stabilization of tetracycline base in dry form with glucono delta lactone
US3145228A (en) 1962-09-06 1964-08-18 Pfizer & Co C 5-alkoxy-and 5-benzyloxy-tetracycline, derivatives and analogues thereof
US3219529A (en) 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US4038315A (en) 1972-05-11 1977-07-26 American Cyanamid Company Isolation and recovery of calcium chloride complex of 7-dimethylamino-6-dimethyl l-6-deoxytetracycline hydrochloride
DE2748132A1 (de) 1977-10-27 1979-05-03 Behringwerke Ag Stabilisator fuer polysaccharid
US4457916A (en) 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
US4678812A (en) 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US5122519A (en) 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
EP0779603B1 (en) 1990-06-22 2002-03-27 Canon Kabushiki Kaisha Image processing apparatus
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5538954A (en) 1994-06-24 1996-07-23 A/S Dumex (Dumex Ltd.) Salts of tetracyclines
US5675030A (en) * 1994-11-16 1997-10-07 American Cyanamid Company Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US5908838A (en) 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
EP1212050B1 (en) 1999-09-14 2006-12-06 Mucosal Therapeutics LLC Formulations containing tetracyclines for treating or preventing mucositis
WO2002012170A1 (en) 2000-08-04 2002-02-14 Trustees Of Tufts College 8-substituted tetracycline compounds
EP1360316A2 (en) 2001-01-11 2003-11-12 Board of Regents, The University of Texas System Dosage adjustement for antibiotics
EP1401402B1 (en) 2001-05-29 2016-09-07 Takeda Pharmaceuticals U.S.A., Inc. Enhancement of oral bioavailability of non-emulsified formulation of cefditoren pivoxil with lecithin
EP2327409A1 (en) 2001-07-13 2011-06-01 Paratek Pharmaceuticals, Inc. Tetracycline compound having target therapeutic activities
US20030171340A1 (en) 2002-02-07 2003-09-11 Jenefir Isbister Methods of disease treatment using metal-complexed tetracycline antibiotics
CN1390550A (zh) * 2002-07-25 2003-01-15 于航 盐酸米诺环素冻干粉针剂及其制备方法
CA2503446C (en) 2002-10-24 2012-12-18 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate rna
WO2004078111A2 (en) 2003-03-06 2004-09-16 Ranbaxy Laboratories Limited Extended release minocycline compositions and processes for their preparation
CN1568999A (zh) † 2003-07-14 2005-01-26 南宁枫叶药业有限公司 稳定的医药用河豚毒素冷冻干燥制剂
US20050148553A1 (en) 2003-09-05 2005-07-07 Testa Raymond T. Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
GB2414668B (en) 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
ATE415973T1 (de) 2004-10-28 2008-12-15 Wyeth Corp Gemeinsame gabe von tigecyclin und digoxin
EP1858488B2 (en) 2005-03-14 2022-07-20 Wyeth LLC Tigecycline compositions and methods of preparation
AR057034A1 (es) 2005-05-27 2007-11-14 Wyeth Corp Metodos para purificar tigeciclina
EP3003273A1 (en) † 2013-05-31 2016-04-13 Xellia Pharmaceuticals ApS A method for stabilizing tigecycline

Also Published As

Publication number Publication date
JP2008533146A (ja) 2008-08-21
KR20130122988A (ko) 2013-11-11
DK1858488T4 (da) 2022-09-12
DK1858488T3 (da) 2013-11-04
EP1858488B1 (en) 2013-09-11
EP1858488B2 (en) 2022-07-20
JP4972081B2 (ja) 2012-07-11
US9694078B2 (en) 2017-07-04
GT200600112A (es) 2006-11-29
AU2006223226B2 (en) 2012-03-15
PT1858488E (pt) 2013-11-18
ZA200707831B (en) 2011-02-23
PL1858488T5 (pl) 2024-01-03
US20110118216A1 (en) 2011-05-19
AR109500A2 (es) 2018-12-19
ES2434944T3 (es) 2013-12-18
CA2602089A1 (en) 2006-09-21
US10588975B2 (en) 2020-03-17
US20160144036A1 (en) 2016-05-26
TW200700092A (en) 2007-01-01
US8975242B2 (en) 2015-03-10
CN101132775A (zh) 2008-02-27
IL185924A0 (en) 2008-01-06
US7879828B2 (en) 2011-02-01
HN2006011218A (es) 2008-09-17
CR9416A (es) 2008-03-06
KR20080002828A (ko) 2008-01-04
KR101354093B1 (ko) 2014-01-24
RU2007131396A (ru) 2009-04-20
AU2006223226A1 (en) 2006-09-21
CA2602089C (en) 2013-04-30
IL185924A (en) 2014-05-28
WO2006099258A8 (en) 2007-10-04
ES2434944T5 (es) 2022-10-20
WO2006099258A1 (en) 2006-09-21
BRPI0608464A2 (pt) 2010-01-05
US20060247181A1 (en) 2006-11-02
CY1114504T1 (el) 2016-10-05
MX2007010983A (es) 2007-09-19
RU2428190C2 (ru) 2011-09-10
CN102512429A (zh) 2012-06-27
EP1858488A1 (en) 2007-11-28
AR053827A1 (es) 2007-05-23
NO20074278L (no) 2007-11-20
US20150141379A1 (en) 2015-05-21
PE20061107A1 (es) 2006-12-08
US20170266290A1 (en) 2017-09-21
US9254328B2 (en) 2016-02-09

Similar Documents

Publication Publication Date Title
IL185924A0 (en) Tigecycline compositions and methods of preparation
IL187360A0 (en) Tigecycline and methods of preparation
IL187539A0 (en) Tigecycline and methods of preparing 9-nitrominocycline
IL190885A0 (en) Immunogenic compositions and methods of use
IL187358A0 (en) Tigecycline and methods of preparing 9-aminominocycline
IL189011A0 (en) COMPOSITIONS OF tRNA AND USES THEREOF
PT2101766T (pt) Composições e métodos de utilização de (r)-pramipexole
IL189364A0 (en) Estrogen compositions and therapeutic methods of use thereof
PL2335782T3 (pl) Zastosowanie kompozycji zawierającej HFCO-1233zd
IL186490A0 (en) Multicyclic compounds and methods of their use
ZA200805640B (en) Terpene-containing compositions and methods of making and using them
ZA200710151B (en) Crystalline solid forms of tigecycline and methods of preparing same
PL1891208T3 (pl) Nowe, oparte na komórkach kompozycje oraz sposoby ich wytwarzania
PL2101766T3 (pl) Kompozycje i sposoby stosowania (R)-pramipeksolu
SI3255115T1 (sl) Sestavki, ki sestojijo iz HFC-1234YF in HFC-134A
IL186606A0 (en) Compositions and uses of amooranin compounds
IL180195A0 (en) Aequorin-containing compositions and methods of using same
EP1928252A4 (en) PIGGY COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE
IL186277A0 (en) Dnt-maleate and methods of preparation thereof
GB0520930D0 (en) Composition and method of use
GB0504657D0 (en) Compositions and methods of treatment
SI1858488T1 (sl) Tigeciklinski sestavki in postopki priprave
HK1110532A (en) Tigecycline compositions and methods of preparation
IL195845A0 (en) Methods of making and using rubidium-81-containing compositions
HK1113131A (en) Tigecycline and methods of preparation